Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site

Valuation: CellaVision AB

Capitalization 5.1B 463M 441M 411M 366M 652M 39.25B 716M 1.89B 16.09B 1.74B 1.7B 69.27B P/E ratio 2024 *
34.9x
P/E ratio 2025 * 26x
Enterprise value 4.97B 451M 429M 400M 356M 635M 38.21B 697M 1.84B 15.67B 1.69B 1.66B 67.45B EV / Sales 2024 *
6.69x
EV / Sales 2025 * 5.77x
Free-Float
82.65%
Yield 2024 *
1.13%
Yield 2025 * 1.39%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.05%
1 week-3.61%
Current month-2.29%
1 month-10.67%
3 months-20.34%
6 months-18.67%
Current year+0.71%
More quotes
1 week
204.50
Extreme 204.5
226.00
1 month
204.50
Extreme 204.5
251.00
Current year
185.20
Extreme 185.2
302.00
1 year
164.00
Extreme 164
302.00
3 years
120.00
Extreme 120
394.50
5 years
120.00
Extreme 120
503.50
10 years
36.00
Extreme 36
503.50
More quotes
Director TitleAgeSince
Chief Executive Officer 53 2021-03-20
Chief Executive Officer 58 2020-11-27
Investor Relations Contact - -
Manager TitleAgeSince
Director/Board Member 59 -
Director/Board Member 60 2018-05-03
Chairman 62 2021-04-28
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.05%-3.61%+23.55%-32.31%463M
+0.40%-1.47%-25.28%-61.00%14.13B
-2.17%-2.24%-42.13%-72.92%2.69B
+2.71%+8.74%-15.11% - 1.47B
-1.41%+2.82%-9.66%+200.63%1.4B
+2.44%+7.38%+33.52%-34.16%1.16B
-2.67%-3.25%-26.33%+38.49%897M
-0.81%+4.58%-27.71%-62.31%882M
+1.51%-0.72%+16.40%-50.69%759M
-0.18%-0.85%-12.93%-42.26%673M
Average -0.12%+0.61%-8.57%-12.95% 2.45B
Weighted average by Cap. +0.08%-0.40%-20.42%-39.88%
See all sector performances

Financials

2024 *2025 *
Net sales 742M 67.39M 64.11M 59.72M 53.23M 94.8M 5.71B 104M 275M 2.34B 253M 248M 10.08B 849M 77.06M 73.3M 68.28M 60.86M 108M 6.53B 119M 315M 2.68B 290M 283M 11.52B
Net income 146M 13.26M 12.62M 11.75M 10.47M 18.65M 1.12B 20.48M 54.17M 461M 49.82M 48.71M 1.98B 196M 17.78M 16.91M 15.75M 14.04M 25.01M 1.51B 27.46M 72.62M 618M 66.8M 65.31M 2.66B
Net Debt -135M -12.21M -11.61M -10.82M -9.64M -17.18M -1.03B -18.86M -49.87M -424M -45.87M -44.85M -1.83B -210M -19.03M -18.1M -16.86M -15.03M -26.77M -1.61B -29.38M -77.72M -661M -71.49M -69.89M -2.84B
More financial data * Estimated data
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
0
Calendar
More about the company
Date Price Change Volume
24-12-04 212.00 kr -0.93% 116,479
24-12-03 214.00 kr -0.47% 8,796
24-12-02 215.00 kr -1.60% 23,305
24-11-29 218.50 kr -2.46% 81,906
24-11-28 224.00 kr +1.13% 38,112

Delayed Quote Nasdaq Stockholm, December 04, 2024 at 04:30 am EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C+
surperformance-ratings-light-chart CELLAVISION-ABMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
214.00SEK
Average target price
270.00SEK
Spread / Average Target
+26.17%
Consensus

Quarterly revenue - Rate of surprise

Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW